HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Graft-vs-host disease following allogeneic hematopoietic cell transplantation.

AbstractBACKGROUND:
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative therapy with proven efficacy in the management of hematologic malignancies. However, it is complicated by the syndromes of acute and chronic graft-vs-host disease (GVHD).
METHODS:
A narrative review is provided to summarize major biologic insights into the pathogenesis of these immune-mediated disorders, as well as advances in diagnosis, classification, prevention, management, and allied supportive care with the aim of providing essential understanding for clinicians with or without subspecialty experience in the field of blood and marrow transplantation.
RESULTS:
Major scientific advances have contributed to enhanced understanding of the pathogenesis of these disorders, and clinical investigation has provided more effective preventive and therapeutic strategies for GVHD. However, since acute GVHD and chronic GVHD remain leading sources of transplantation-related morbidity and mortality, ongoing investigation is needed to develop new approaches to addressing these syndromes.
CONCLUSIONS:
The major challenge for future investigation will be to capitalize on biologic insights in order to develop novel strategies for the prevention and therapy of acute and chronic GVHD that will address the current shortcomings in existing therapeutic approaches.
AuthorsJoseph Pidala
JournalCancer control : journal of the Moffitt Cancer Center (Cancer Control) Vol. 18 Issue 4 Pg. 268-76 (Oct 2011) ISSN: 1526-2359 [Electronic] United States
PMID21976245 (Publication Type: Journal Article, Review)
Chemical References
  • Glucocorticoids
Topics
  • Acute Disease
  • Chronic Disease
  • Drug Therapy, Combination
  • Glucocorticoids (therapeutic use)
  • Graft vs Host Disease (diagnosis, drug therapy, etiology)
  • Hematopoietic Stem Cell Transplantation (adverse effects, methods)
  • Humans
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: